U.S. Markets closed

Amgen’s Court Win Could Mark ‘a New Dawn’ for the Stock

Josh Nathan-Kazis

The biotech company Amgen won a lawsuit Friday that likely protects its patents on its blockbuster rheumatoid arthritis drug Enbrel until 2029.